GlassScriptPhysician profile
Gazi Abdulhay
NPI 1548210024
$10,361.21
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,077 · 2020: $75.42 · 2021: $53.84 · 2022: $8,070 · 2023: $84.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $56.56 · Food and Beverage: $28.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $56.56 |
| Food and Beverage | $28.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,078.73 | 2022-2023 | Da Vinci Surgical System |
| Olympus Corporation of The Americas | $1,202.60 | 2019 | |
| Tesaro, INC. | $243.23 | 2019 | |
| Becton, Dickinson and Company | $177.18 | 2019 | |
| Kyowa Kirin, INC. | $79.12 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $74.10 | 2019 | |
| Glaxosmithkline, LLC. | $62.49 | 2020 | |
| Karyopharm Therapeutics INC. | $53.84 | 2021 | |
| Coopersurgical, INC. | $47.79 | 2022 | |
| Genentech USA, INC. | $46.61 | 2019 | |
| Puma Biotechnology, INC. | $32.06 | 2019 | |
| Davol INC. | $31.37 | 2019 | |
| Celgene Corporation | $31.28 | 2019-2020 | |
| Daiichi Sankyo INC. | $22.71 | 2019 | |
| Foundation Medicine, INC. | $18.94 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.37 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.28 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $16.65 | 2019 | |
| Aveo Pharmaceuticals, INC. | $14.75 | 2023 | Fotivda |
| Abbvie INC. | $14.52 | 2019 | |
| Smith+Nephew, INC. | $13.65 | 2019 | |
| Amgen INC. | $13.54 | 2023 | Evenity, Prolia |
| Clovis Oncology, INC. | $13.30 | 2019 | |
| Janssen Biotech, INC. | $12.72 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.25 | 2019 | |
| Spectrum Pharmaceuticals INC. | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gazi Abdulhay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.